Document is current
Any future updates will be listed below
-
Authors
Chin, Joseph J. https://orcid.org/0000-0003-3123-5091
Walls, W. Daniel https://orcid.org/0000-0002-8539-0049
Wang, Kai https://orcid.org/0000-0002-3229-9866
Odell, Amanda M. https://orcid.org/0000-0003-0212-4683
Kolbe, Diana L. https://orcid.org/0000-0003-0827-1473
Booth, Kevin T. A. https://orcid.org/0000-0003-3061-3652
Azaiez, Hela https://orcid.org/0000-0002-2863-6970
Smith, Richard J. H. https://orcid.org/0000-0003-1201-6731
-
Funding
Funding for this research was provided by:
National Institutes of Health—National Institute of General Medical Sciences (GM139776, GM139776)
National Institutes of Health—National Institute on Deafness and Other Communication Disorders (DC002842)
- License Information
-
More Information
Article History
Received: 10 June 2025
Accepted: 14 September 2025
First Online: 29 September 2025
Declarations
:
: RJHS directs the Molecular Otolaryngology and Renal Research Laboratories, which provides comprehensive genetic testing for the clinical evaluation of hearing loss.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University of Iowa on March 6, 2025 (IRB-01 # 201602772 and 199701065). Informed consent was obtained from all individual participants included in the study.
